
Remepy is pioneering hybrid drugs, which are a new class of pharmaceutical assets that combine traditional drugs with proprietary software-based digital interventions. These "digital molecules" are therapeutic mobile apps designed to trigger physiological effects through the brain, thereby enhancing the effectiveness of conventional drugs. The company's approach redefines combination therapy by integrating software with drugs to create SaMD (Software as a Medical Device) drug combinations, enabling personalized treatment at scale. Remepy focuses on diseases where changes in brain connectivity, immune system modulation, and behavioral adjustments are synergistic with drug effects, with current areas of interest including Parkinson's Disease, Oncology, and Women's Health. They leverage AI-driven digital treatment protocols that adapt based on patient feedback, activity, and progress to optimize drug performance and address symptoms.

Remepy is pioneering hybrid drugs, which are a new class of pharmaceutical assets that combine traditional drugs with proprietary software-based digital interventions. These "digital molecules" are therapeutic mobile apps designed to trigger physiological effects through the brain, thereby enhancing the effectiveness of conventional drugs. The company's approach redefines combination therapy by integrating software with drugs to create SaMD (Software as a Medical Device) drug combinations, enabling personalized treatment at scale. Remepy focuses on diseases where changes in brain connectivity, immune system modulation, and behavioral adjustments are synergistic with drug effects, with current areas of interest including Parkinson's Disease, Oncology, and Women's Health. They leverage AI-driven digital treatment protocols that adapt based on patient feedback, activity, and progress to optimize drug performance and address symptoms.
About Remepy
Remepy is pioneering a new category of therapy by combining pharmaceuticals with targeted digital interventions. Our mission is to deliver more personalized, adaptive, and effective care - helping patients heal through the unified power of biology, behavior, and technology. We’re a team of scientists, technologists, clinicians, and creators driven by one belief: the future of medicine is multidimensional.
Responsibilities
· Establish the operational infrastructure for a Pha se III clinical trial in Israel
· Lead and manage submissions to IRBs (Helsinki Committees)
· Initiate clinical sites and oversee site activation processes
· Perform monitoring and provide ongoing management and support to trial sites in Israel
· Arrange and coordinate all local logistics related to the clinical trial
· Support the VP of Clinical Operations with study documentation, study setup, and global-level clinical trial activities
Qualifications
· Bachelor’s degree or higher in Life Sciences or a paramedical profession (e.g., nursing, pharmacy, clinical dietetics, etc.)
· Minimum of 2-3 years of experience in clinical research within pharmaceutical, medical device, or CRO environments
· Strong understanding of site-level clinical trial management, including monitoring, investigational product handling, and regulatory binder management
· In-depth knowledge of Israeli clinical trial regulations and ICH-GCP guidelines
· Proven experience managing site submissions and site-level regulatory documentation
· Willingness to travel to clinical trial sites across Israel
· GCP certification
· CRA certification- advantage
· Experience with Phase III trials – advantage
· Knowledge or experience in Parkinson’s disease – advantage
· Experience working in a startup environment – advantage